Their CEO is going in front of Congress to explain the huge price increase for Epipens.
This was copied from a yahoo story:
In her testimony, Bresch says she understands there is considerable concern and skepticism about the pricing. She says some think the company makes $600 off each EpiPen, but that is not true.
She says the company makes about $50 per pen after rebates, fees, materials and other costs are subtracted.